The European Antiseptics and Disinfectants Market size is anticipated to grow at 6.54% CAGR from 2021 to 2026. As per our report, the market was valued at USD 2.48 billion in 2021 and is expected to grow USD 3.41 billion by 2026. Following North America, Europe is dominating the global market. Initiative steps by government and non-government organizations to develop quality products in concern towards public safety bolstered the growth rate of the antiseptics and disinfectants market.
Growing investments in hospitals and clinics by both public and private organizations, the rise in the flow of patients to the hospitals, high prevalence to avoid the spread of infections from one person to another by maintaining hygienic conditions are the key factors lavishing the growth of the European antiseptics and disinfectants market. Additionally, increasing demand for the prevention of growth of microbe and other microorganisms in testing kits, medical devices, and surgical instrumentations and a growing number of surgical operations due to a rise in the number of patients suffering from chronic and other diseases are further propelling the growth rate of the Europe antiseptics and disinfectants market.
However, rapid changes in economic strategies are impacting negatively on the growth of the market. Decreasing the products' quality due to the negligence of the manufacturers in pharmaceutical companies is slightly impeding the demand of the antiseptics and disinfectants market in Europe. Lack of sufficient knowledge among staff members in the utilization of disinfectants in clinics has remained challenging for the market developers.
This report on the European antiseptics and disinfectants market has been segmented & sub-segmented into the following categories:
Geographically, In Europe, the UK holds the largest shares of the antiseptics and disinfectants market. The rise in the number of people suffering from different health disorders is fueling the market's growth rate. Increasing demand to provide quality treatment services is also a factor escalating the demand of the market.
The German antiseptics and disinfectants market is expected to hit the highest CAGR in the coming years. The rise in the demand to manufacture a greater number of products to reach the requirements is leveraging the growth rate of the antiseptics and disinfectants market. Improvements in the healthcare infrastructure are also elevating the growth rate of this market.
Following the UK, France has prominent shares of the market due to rising prevalence to control the spread of coronavirus by sanitizing. Support from government organizations through funds is likely to level up the growth rate of the market in this country.
In Spain, antiseptics and disinfectants market shares are leveraging rapidly due to increasing cases of COVID-19. Increasing demand for disinfecting the surfaces with chemical agents to kill microorganisms is lavishing the growth rate of the market in this country. The rising number of hospitals and clinics is also a factor boosting the market demand in this country.
Italy is also likely to hold prominent shares of the market following Spain. Increasing life-threatening diseases like COVID-19 is a major factor for the market to grow enormously in this country. Also, the growing demand for frequently sanitizing, especially in public areas, is to surge the growth rate of the market.
Companies playing a dominating role in the European Antiseptics and Disinfectants Market profiled in this report are 3M Company, Abc Compounding, Advanced Sterilization Products, American Biotech Labs, Angelini Pharma Inc., Becton, Dickinson And Company, Bio-Cide International Inc., Cardinal Health and Carefusion Corp.
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3.1 Executive Summary
3.2 Key Inferences
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 End User
5.1.2 Domestic User
5.1.3 Institutional User
5.1.4 Y-o-Y Growth Analysis, By End User
5.1.5 Market Attractiveness Analysis, By End User
5.1.6 Market Share Analysis, By End User
5.2.2 Alcohol and Aldehyde
5.2.3 Phenols and Derivatives
5.2.4 Biguanides and Amides
5.2.5 Quaternary Ammonium Compounds
5.2.6 Iodine Compounds
5.2.8 Y-o-Y Growth Analysis, By Type
5.2.9 Market Attractiveness Analysis, By Type
5.2.10 Market Share Analysis, By Type
6. Geographical Analysis
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
184.108.40.206 By Geographical Area
220.127.116.11 By End User
18.104.22.168 By Type
6.1.4 Market Attractiveness Analysis
22.214.171.124 By Geographical Area
126.96.36.199 By End User
188.8.131.52 By Type
6.1.5 Market Share Analysis
184.108.40.206 By Geographical Area
220.127.116.11 By End User
18.104.22.168 By Type
7. Strategic Analysis
7.1 PESTLE analysis
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 3M Company
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Abc Compounding
8.3 Advanced Sterilization Products
8.4 American Biotech Labs
8.5 Angelini Pharma Inc.
8.6 Becton, Dickinson And Company
8.7 Bio-Cide International Inc.
8.8 ICardinal Health
8.9 Carefusion Corp.
8.10 Nufarm Limited
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
a) List of Tables
b) List of Figures